By Professor Glenda Halliday

Journal articles

Kipps C; Davies R; Mitchell J; Kril J; Halliday GM; Hodges JR, 2007, 'Clinical significance of lobar atrophy in frontotemporal dementia: Application of an MRI visual rating scale', Dementia and Geriatric Cognitive Disorders, 23, pp. 334 - 342

Dedov V; Griffiths F; Garner B; Halliday GM; Double KL, 2007, 'Lipid content determines aggregation of neuromelanin granules in vivo', Journal of Neural Transmission - Supplement, 72, pp. 35 - 38

Cairns NJ; Bigio E; Mackenzie IR; Neumann M; Lee VM; Hatanpaa K; White CL; Schneider JA; Grinberg LT; Halliday GM; Duyckaerts C; Lowe JL; Holm I; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson D; Ince PG; Trojanowski JQ; Mann DM, 2007, 'Neuropathological diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration', ACTA Neuropathologica, 114, pp. 5 - 22

Song YC; Lundvig DM; Huang Y; Gai WP; Blumbergs PC; Hojrup P; Otzen D; Halliday GM; Jensen PH, 2007, 'p25alpha relocalizes in oligodedroglia from myelin to cytoplasmic inclusions in multiple system atrophy', American Journal of Pathology, 171, pp. 1291 - 1303

Taylor JM; Song YC; Huang Y; Farrer M; Delatycki MB; Halliday GM; Lockhart PJ, 2007, 'Parkin co-regulated gene (PACRG) is regulated by the ubiquitin-proteasomal system and is present in the pathological features of parkinsonian diseases', Neurobiology of Disease, 27, pp. 238 - 247

Huang Y; Halliday GM; Vandebona H; Mellick GD; Mastaglia F; Stevens J; Kwok JB; Garlepp M; Silburn PA; Horne MK; Kotschet K; Venn A; Rowe DB; Rubio J; Sue C, 2007, 'Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson`s disease', Movement Disorders, 27, pp. 982 - 989

Shepherd CE; Grace E; Mann DM; Halliday GM, 2007, 'Relationship between neuronal loss and 'inflammatory plaques' in early onset Alzheimer's disease', Neuropathology and Applied Neurobiology, 33, pp. 328 - 333

Behnke S; Double KL; Duma SR; Broe T; Guenther V; Becker GJ; Halliday GM, 2007, 'Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing', Neuroimage, 34, pp. 1054 - 1059

Sutherland GR; Nowak G; Halliday GM; Kril J, 2007, 'Tau isoform expression in frontotemporal dementia without tau deposition', Journal of Clinical Neuroscience, 14, pp. 1182 - 1185

Litvan I; Halliday GM; Hallett M; Goetz CG; Rocca W; Duyckaerts C; Ben-Shlomo Y; Dickson D; Lang A; Chesselet M; Langston WJ; Di Monte DA; Gasser T; Hagg T; Hardy J; Jenner P; Melamed E; Myers RH; Parker Jr D; Price D, 2007, 'The etiopathogenesis of Parkinson Disease and suggestions for future research. Part 1', Journal of Neuropathology and Experimental Neurology, 66, pp. 251 - 257

Litvan I; Chesselet M; Gasser T; Di Monte DA; Parker Jr D; Hagg T; Hardy J; Jenner P; Myers RH; Price D; Hallett M; Langston WJ; Lang A; Halliday GM; Rocca W; Duyckaerts C; Dickson D; Ben-Shlomo Y; Goetz CG; Melamed E, 2007, 'The etiopathogenesis of parkinson disease and suggestions for future research. Part II', Journal of Neuropathology and Experimental Neurology, 66, pp. 329 - 336

Fedorow H; Halliday GM; Rickert CH; Gerlach M; Riederer P; Double KL, 2006, 'Evidence for specific phases in the development of human neuromelanin', Neurobiology of Aging, 27, pp. 506 - 512, http://dx.doi.org/10.1016/j.neurobiolaging.2005.02.015

Ritchie CW; Chiu E; Harrigan S; Macfarlane S; Mastwyk M; Halliday G; Hustig H; Hall K; Hassett A; O'Connor DW; Opie J; Nagalingam V; Snowdon J; Ames D, 2006, 'A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration', INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 21, pp. 171 - 179, http://dx.doi.org/10.1002/gps.1446

Piguet O; Bennett HP; Waite LM; Kril JJ; Creasey H; Broe GA; Halliday GM, 2006, 'Absence of cognitive deficits and preserved functional independence after a large right PCA infarct: Longitudinal clinical and neuropathological findings', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 58, pp. 229 - 229, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000242541400830&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ooi T; Barnetson RS; Zhuang L; McKane S; Lee JH; Slade HB; Halliday GM, 2006, 'Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: A randomized controlled trial', British Journal of Dermatology, 154, pp. 72 - 78, http://dx.doi.org/10.1111/j.1365-2133.2005.06932.x

de Silva R; Lashley T; Strand C; Shiarli A; Shi J; Tian J; Bailey K; Davies P; Bigio E; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday GM; MacKenzie J; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown S; Holton J; Lees A; Revesz T; Mann DM, 2006, 'An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R-and 4R-specific tau monoclonal antibodies', ACTA Neuropathologica, 111, pp. 329 - 340

Huang Y; Hayes M; Harding AJ; Brooks WS; Fung VS; Rowe DB; Joffe R; Crimmins D; Hely MA; Halliday GM, 2006, 'Anticipation of onset age in familial Parkinson`s disease without SCA gene mutations', Parkinsonism and Related Disorders, 12, pp. 309 - 313

Rahimi F; Shepherd CE; Halliday GM; Geczy C; Raftery MJ, 2006, 'Antigen-epitope retrieval to facilitate proteomic analysis of formalin-fixed archival brain tissue', Analytical Chemistry, 78, pp. 7216 - 7221, http://dx.doi.org/10.1021/ac060294s

David DJ; Ittner L; Gehrig P; Nergenau D; Shepherd CE; Halliday GM; Gotz J, 2006, 'Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes', Proteomics, 6, pp. 6566 - 6577

Bennett HP; Piguet O; Grayson DA; Creasey H; Waite LM; Lye TC; Broe T; Halliday GM, 2006, 'Cognitive, Extrapyramidal, and Magnetic Resonance Imaging Predictors of Functional Impairment in Nondemented Older Community Dwellers: The Sydney Older Person Study', Journal of American Geriatrics Society, 54, pp. 3 - 10

Shiarli A; Jennings R; Shi J; Bailey K; Davidson Y; Tian J; Bigio E; Ghetti B; Murrell J; Delisle M; Mirra S; Crain B; Zolo P; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday GM; MacKenzie J; Khan N; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown S; Mann DM, 2006, 'Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease', Neuropathology and Applied Neurobiology, 32, pp. 374 - 387

Cordato N; Halliday GM; Caine D; Morris JG, 2006, 'Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson`s disease', Movement Disorders, 21, pp. 632 - 638

Halliday GM; Del Tredici K; Braak H, 2006, 'Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson`s disease', Journal of Neural Transmission - Supplement, pp. 99 - 103

Gregory GC; Macdonald V; Schofield PR; Kril J; Halliday GM, 2006, 'Differences in regional brain atrophy in genetic forms of Alzheimer's disease', Neurobiology of Aging, 27, pp. 387 - 393

Halliday GM; Fedorow HS; Rickert C; Gerlach M; Riederer P; Double KL, 2006, 'Evidence for specific phases in the development of human neuromelanin', Journal of Neural Transmission, 113, pp. 721 - 728

Shepherd CE; Goyette JD; Utter V; Rahimi F; Yang Z; Geczy C; Halliday GM, 2006, 'Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease', Neurobiology of Aging, 27, pp. 1554 - 1563

Fedorow HS; Pickford R; Kettle E; Cartwright M; Halliday GM; Gerlach M; Riederer P; Garner B; Double KL, 2006, 'Investigation of the lipid component of neuromelanin', Journal of Neural Transmission, 113, pp. 735 - 739

Pickering-Brown S; Baker M; Gass J; Boeve B; Loy CT; Brooks WS; Mackenzie IR; Martins RN; Kwok JB; Halliday GM; Kril J; Schofield PR; Mann DM; Hutton M, 2006, 'Mutations in progranulin explain atypical phenotypes with variants in MAPT', Brain, 129, pp. 3124 - 3126

Halliday GM; Song YC; Creasey H; Morris JC; Brooks WS; Kril J, 2006, 'Neuropathology in the S305S tau gene mutation', Brain, 129, pp. E40 - E40

Double KL; Halliday GM, 2006, 'New face of neuromelanin', Journal of Neural Transmission, pp. 119 - 123

Baker K; Huang Y; Mccann H; Gai WP; Jensen PH; Halliday GM, 2006, 'P25 alpha immunoreactive but alpha-synuclein immunonegative neuronal inclusions in multiple system atrophy', ACTA Neuropathologica, 111, pp. 193 - 195

Piguet O; Bennett HP; Waite LM; Kril J; Creasey H; Broe T; Halliday GM, 2006, 'Preserved Cognition and Functional Independence after a Large Right Posterior Cerebral Artery Infarct: Longitudinal Clinical and Neuropathological Findings', Neurocase, 12, pp. 81 - 90

Davies R; Kipps CM; Mitchell J; Kril J; Halliday GM; Hodges JR, 2006, 'Progression in frontotemporal dementia: Identifying a benign behavioral variant by magnetic resonance imaging', Archives of Neurology, 63, pp. 1627 - 1631

Halliday G, 2006, 'S2–02–04: The status of a–synuclein in Alzheimer cases with and without Lewy bodies', Alzheimer's & Dementia, 2, http://dx.doi.org/10.1016/j.jalz.2006.05.084

Götz J; David D; Ittner L; Halliday G; Shepherd C, 2006, 'S5–03–01: Animal and cellular models – tau–Abeta interaction', Alzheimer's & Dementia, 2, http://dx.doi.org/10.1016/j.jalz.2006.05.362

Kersaitis C; Halliday GM; Xuereb J; Pamphlett R; Bak T; Hodges JR; Kril J, 2006, 'Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neuron disease identifies a group with mainly early pathology', Neuropathology and Applied Neurobiology, 32, pp. 83 - 91

Halliday GM, 2005, 'Activation of molecular adaptation to sunlight - A new approach to photoprotection', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 125, pp. XVIII - XIX, http://dx.doi.org/10.1111/j.0022-202X.2005.23940.x

Byrne SN; Halliday GM, 2005, 'B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 124, pp. 570 - 578, http://dx.doi.org/10.1111/j.0022-202X.2005.23615.x

Kuchel J; Barnetson R; Zhuang L; Strickland F; Pelley R; Halliday G, 2005, 'Tamarind Inhibits Solar-Simulated Ultraviolet Radiation-Induced Suppression of Recall Responses in Humans', Letters in Drug Design & Discovery, 2, pp. 165 - 171, http://dx.doi.org/10.2174/1570180053175106

Osborne PB; Halliday GM; Cooper HM; Keast JR, 2005, 'Localization of immunoreactivity for deleted in colorectal cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents', Neuroscience, 131, pp. 671 - 681, http://dx.doi.org/10.1016/j.neuroscience.2004.11.043

Demangel C; Zhou J; Choo ABH; Shoebridge G; Halliday GM; Britton WJ, 2005, 'Single chain antibody fragments for the selective targeting of antigens to dendritic cells', Molecular Immunology, 42, pp. 979 - 985, http://dx.doi.org/10.1016/j.molimm.2004.09.034

Halliday GM; Macdonald V; Henderson JM, 2005, 'A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson`s disease', Brain, 128, pp. 2272 - 2280

Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM, 2005, 'A possible role for humoral immunity in the pathogenesis of Parkinson`s disease', Brain, 128, pp. 2665 - 2674

Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow HS; Cartwright M; Griffiths F; Shepherd CE; Double KL, 2005, 'alpha-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson`s disease', Brain, 128, pp. 2654 - 2664

Halliday GM, 2005, 'Clarifying Lewy-body parkinsonism with visual hallucinations', Lancet Neurology, 4, pp. 588 - 589, http://www.sciencedirect.com/science/article/B6X3F-4H45CPY-3/2/d0658ca7b44b7d4ecad2a629a838549c

Cordato N; Duggins A; Halliday GM; Morris JG; Pantelis C, 2005, 'Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy', Brain, 128, pp. 1259 - 1266

McKeith IG; Dickson DW; Lowe J; Emre M; O Brien J; Feldman H; Cummings J; Duda JE; Lippa C; Perry EK; Aarsland D; Arai H; Ballard CG; Boeve B; Burn D; Costa D; Del Ser T; Dubois B; Galasko D; Gauthier S; Goetz CG; Gomez-Tortosa E; Halliday GM; Hansen L; Hardy J; Iwatsubo T; Kalaria RN; kaufer D; Kenny RA; Korczyn A; Kosaka K; Lee V; Lees A; Litvan I; Londos E; Lopez O; Minoshima S; Mizuno Y; Molina JA; Mukaetova-Ladinska EB; Pasquier F; Perry RH; Schulz JB; Trojanowski JQ; Yamada M, 2005, 'Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium.', Neurology, 65, pp. 1863 - 1872

Li J; Scheller C; Koutsilieri E; Griffiths F; Beart PM; Mercer L; Halliday GM; Kettle E; Rowe DB; Riederer P; Gerlach M; Rodriguez M; Double KL, 2005, 'Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells', Journal of Neurochemistry, 95, pp. 599 - 608

Kril J; Macdonald V; Patel S; Png F; Halliday GM, 2005, 'Distribution of brain atrophy in behavioral variant frontotemporal dementia', Journal of the Neurological Sciences, 232, pp. 83 - 90, http://www.sciencedirect.com/science/article/B6T06-4FV366B-2/2/4d8e5edbf20b0dee1ab507d7748b65dd

Fedorow HS; Pickford R; Hook JM; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B, 2005, 'Dolichol is the major lipid component of human substantia nigra neuromelanin', Journal of Neurochemistry, 92, pp. 990 - 995

Back to profile page